Member Info for Soupdragon78

Never regret a profit.

The market will always present opportunities.

Filter, just looked back through all of todays posts and the closest anyone gets is 'blue by end of week'.

Someone else said it belongs around the 10p mark, but didn't state when.

Hardly ramping is it?

If no one can predict, does that mean nobody should bother investing in anything?

Thats what the company would look to do. NFX would happily develop a drug to then sell on as LifeArc recently did with Keytruda for over $1.3bn. (LifeArcs ex-CEO is NFX chairman now)

Imagine buying at around 2p before that as well.

To be fair it was 12 weeks ago as opposed to 'a few'

Chablard, the point being with last years NXP001 milestone the company announced ion 14/09 it had achieved the milestone and triggered payment, that payment was only confirmed as received on 27/11.

So extrapolate the same theory here, there is the trigger announcement, then a period of time, then receipt of payment. Given the importance I would expect Dan to announce when payment is received.

Granted we are over two months on this payment. But I would expect it in the near term. Especially as NFX had always accounted for it in this half of the financial year.

Exactly Halespur, the fact that NSB have a history of paying up should be taken into account. The first NXP001 payment wasn’t notified till over two months after it was triggered, so comparable to now.

Quite how relevant my post below re. Out licensing is to NXP001 is I’m not quite sure. But I think it gives a flavour.

26.1 Cocrystallisation Service Agreement (Licensing Agreements)

On 30 October 2015, Nuformix entered into a cocrystallisation service agreement with Shanghai Newsummit Biopharma Group Company Limited (“NSB”) pursuant to which, inter alia, the parties agreed to conduct cocrystal discovery and development studies on various pharmaceutical ingredients, submit for patent protection for the resulting pharmaceutical cocrystals, submit Chinese IND applications and Nuformix grant NSB a licence to use certain intellectual property rights (three Nuformix patents) for specific purposes, plus access to relevant data.

In total, Nuformix licensed Chinese market rights for 3 of its cocrystal patents to NSB under the terms of this agreement – specifically to pharmaceutical cocrystals of Metaxalone, Cilostazol and Rebamipide. For avoidance of doubt, patents covering the pharmaceutical cocrystals of Metaxalone, Cilostazol and Rebamipide are not relevant at all to the Enlarged Group or its plans or trading prospects going forwards.

Nuformix received a total of £400,000 from NSB as an upfront license fee payment for the three patents. Nuformix will also receive 10 per cent. of all NSB revenues derived from the three patents. It was further agreed that if NSB generates data in China that Nuformix can use, should it choose to develop the three drug molecules covered by its patents outside of China, the parties shall enter negotiations in good faith to determine the appropriate royalty rate to be paid to NSB. The agreement shall expire upon the cessation of all payment obligations. As of 31 August 2016, all amounts payable to Nuformix under this agreement have been received. The agreement may also be terminated by either party by immediate written notice in circumstances of material breach by the either party or if either party (or its parent company) becomes insolvent. NSB may also terminate the agreement by immediate written notice if Nuformix (or any of its affiliates), inter alia, challenges, opposes, disputes or otherwise assists in a third party challenge I of the patents and/or patents applications owned by NSB

Classic thread trashing technique underway here. A couple of newbies turn up with a view to getting people wound up and posting about anything but the company.
Seen it happen time and again, classic shorters way of trashing.

Forget the personal guff, nobody here cares really.

You wouldn't expect a company to RNS every invoice would you?

Also worth noting from the annual report that the Ebers deal includes payments for filing of patents.

Dan, the management understand this, they've been asked about it numerous times, in fact it actually forms part of the final results that were issued as the funding goes to pay for other developments. This is their primary focus at the moment

Dan, the post was saying we needed an update, of which we have had 3 in the past week. I was purely responding to that.

As you say it should have been sorted before, we know that and that doesn't need any update from the company.

He gave an update last week and at the AGM. What more can he say? It has to be worked through.

Albi, whilst I don't know KSW's involvement, PTSD999 has been in trouble for not putting lottery funding money through their books and saying they are a charity whilst not being registered. Not a good look.

DaveW, look up PTSD999 Ltd.

Mornington-oz, hows that take over rumour you were spreading the other day coming along?

Beat me to it with your correct.